ArticleJournal of the Society for Cardiovascular Angiography & Interventions

Design and Rationale of Targeted Therapy With a Sirolimus-Eluting, Biodegradable Polymer Coronary Stent in Chronic Total Occlusions (TARGET CTO): A Multicenter, Open-Label, Randomized Noninferiority Trial.

Yaling Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.